Mark E Smith

Title: Mark E Smith: Innovator in Cardiovascular Therapeutics

Introduction

Mark E Smith is a notable inventor based in Webster Groves, MO (US). He has made significant contributions to the field of cardiovascular therapeutics, holding 2 patents that focus on innovative combinations of therapeutic compounds.

Latest Patents

His latest patents include "Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications." This invention provides combinations of cardiovascular therapeutic compounds aimed at the prophylaxis or treatment of cardiovascular diseases such as hypercholesterolemia, atherosclerosis, or hyperlipidemia. The combinations disclosed include an HMG CoA reductase inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor. Another significant patent is "Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications." This invention also targets cardiovascular diseases and includes combinations of an ileal bile acid transport inhibitor with a CETP inhibitor.

Career Highlights

Throughout his career, Mark E Smith has worked with reputable companies, including G.D. Searle LLC and G.D. Searle & Company. His work has contributed to advancements in cardiovascular treatments, showcasing his dedication to improving patient outcomes.

Collaborations

Mark has collaborated with notable professionals in his field, including Bradley T Keller and James A Sikorski. These collaborations have likely enhanced the development and success of his innovative patents.

Conclusion

Mark E Smith is a distinguished inventor whose work in cardiovascular therapeutics has led to valuable patents that address critical health issues. His contributions continue to influence the field and improve treatment options for patients.